Dogecoin's Value Plummets: The End of the Elon Musk Effect?
Finance

Dogecoin's Value Plummets: The End of the Elon Musk Effect?

authorBy Lisa Jing
DateJun 09, 2026
Read time3 min

Dogecoin (DOGE), a prominent cryptocurrency, has recently experienced a significant downturn, with its value declining by 13% in the past week and now trading at 88% below its all-time high. This decline signals a potential detachment from the influence of Elon Musk, whose past endorsements were a major driving force for the coin's valuation. The broader meme coin market has also been affected, losing substantial market capitalization since late 2024. Despite efforts to integrate Dogecoin into mainstream financial systems through new ETFs and payment platforms, its price has not rebounded, highlighting a challenging period for the digital asset and its peers.

The Diminishing Influence of Elon Musk on Dogecoin's Market Performance

For a considerable period, Dogecoin's market performance was notably sensitive to public comments and actions by Elon Musk, often seeing double-digit surges after his social media posts. However, this correlation appears to have weakened significantly. A recent instance in March, where Musk shared an AI-generated video related to Dogecoin on X, resulted in minimal price movement for the cryptocurrency. This suggests that the market is no longer reacting as strongly to his endorsements, indicating a shift in investor sentiment or a saturation of the 'Musk effect.' The past reliance on such high-profile figures for market momentum may be unsustainable, forcing Dogecoin to seek more fundamental drivers for its value.

Furthermore, the dissolution of the federal Department of Government Efficiency, a perceived catalyst that once propelled DOGE to a $61 billion market cap in November 2024, has further contributed to the coin's struggles. This agency, which shared a similar name with Dogecoin, was prematurely terminated, and Musk explicitly clarified that the government had no intention of utilizing Dogecoin, further severing any speculative ties. The market has since witnessed a staggering reduction of over $47 billion in Dogecoin's market cap since November 2024, with its current valuation standing at $13.4 billion. This stark decline underscores the vulnerability of assets heavily influenced by external, non-fundamental factors and the need for more intrinsic value propositions to sustain long-term growth.

Broader Market Contraction and Technical Outlook for Meme Coins

The challenges faced by Dogecoin are not isolated but reflect a broader downturn within the meme coin sector. The total market capitalization for meme coins, which peaked at $150.6 billion in November 2024, has since plummeted to approximately $38 billion. This substantial contraction highlights a sector-wide correction, where investor enthusiasm for speculative assets has waned. Despite the launch of spot Dogecoin ETFs by notable firms such as Grayscale, 21Shares, and Bitwise, these financial products have collectively attracted a mere $12 million in assets, indicating a lack of significant institutional or retail interest compared to other established cryptocurrencies like Bitcoin and Ethereum, whose ETFs garnered billions in early inflows.

Adding to the sector's woes, other prominent meme coins have also suffered substantial losses. Shiba Inu (SHIB) is down 94.5% from its all-time high, while PEPE and FLOKI have experienced declines of 90% and 93%, respectively. From a technical analysis perspective, Dogecoin is currently holding just above a critical support level at $0.080. The presence of a bearish EMA stack overhead, ranging from $0.09366 to $0.11809, alongside the Bull Market Support Band between $0.09854 and $0.10885 acting as resistance, suggests a confirmed downtrend. Analysts warn that any upward movement below $0.0985 on a daily close should be considered market noise, with the next visible support level not appearing until $0.070 if the $0.080 floor is breached, signaling further potential downside for the coin.

More Articles
Finance
Thornburg International Growth Fund Q1 2026 Performance Analysis
The Thornburg International Growth Fund's I share class achieved a -3.51% return in Q1 2026, slightly outperforming the MSCI ACWI ex-U.S. Growth Index by 11 basis points. This positive relative performance was primarily driven by strategic allocation and stock selection within the Information Technology and Health Care sectors. Geographically, strong stock picking and an overweight position in the Netherlands, alongside favorable selection in France and Germany, were key contributors to the fund's first-quarter results.
By Nouriel RoubiniJun 09, 2026
Finance
Anthropic's New AI Model, Mythos, Challenges the AI Bubble Amid Rising Token Costs and Major IPO Rivalries
Anthropic has unveiled Mythos, its most advanced public AI model, priced at double its predecessor, Claude Opus. This launch coincides with warnings from a senior Wells Fargo strategist about escalating AI token expenses posing a significant threat to the burgeoning AI market. The move positions Anthropic in a high-stakes IPO race against OpenAI and SpaceX, potentially leading to a market liquidity crunch. The article highlights the intricate dynamics of AI innovation, market valuation, and economic stability.
By Mariana MazzucatoJun 09, 2026
Finance
Dynex Capital: A High-Yield Opportunity in Agency RMBS
Dynex Capital (DX) is a high-yield mortgage REIT that offers a nearly 16% yield and exposure to agency residential mortgage-backed securities (RMBS). Despite a negative economic return in Q1 due to rising rates and wider mortgage spreads, future income prospects are strong if funding costs decrease. The stock trades at 1.02x book value, suggesting an 8% price upside to 1.1x book and a 24% total return potential over twelve months. Key risks include interest rate and spread volatility, high leverage, and dividend sustainability if book value continues to decline.
By Michele FerreroJun 09, 2026
Finance
Phathom: Downgrading to 'Sell' Amidst Market Challenges
Phathom Pharmaceuticals faces significant challenges, leading to a downgrade to 'Sell'. Voquezna's growth appears stagnant, failing to expand beyond early adopters. The emergence of Sebela's tegoprazan poses a direct threat to Voquezna's market share and pricing power. Furthermore, the company's valuation relies heavily on optimistic growth and long-term stability, which are questionable given the impending patent cliff in 2033.
By Suze OrmanJun 09, 2026
Finance
Synchrony Bank CD Rates: An In-Depth Analysis
This article explores the features, benefits, and drawbacks of Certificates of Deposit (CDs) offered by Synchrony Bank. It examines the various CD types, their competitive interest rates, and the absence of minimum balance requirements. Additionally, it highlights crucial considerations such as early withdrawal penalties and automatic renewal policies, providing a comprehensive guide for potential investors. The article also compares Synchrony's offerings with alternative savings and investment products.
By Mariana MazzucatoJun 09, 2026